Literature DB >> 3055179

Plasmid-mediated resistance to third-generation cephalosporins caused by point mutations in TEM-type penicillinase genes.

W Sougakoff1, S Goussard, G Gerbaud, P Courvalin.   

Abstract

Infections due to strains of Klebsiella pneumoniae, Escherichia coli, and Citrobacter freundii resistant to third-generation cephalosporins have been observed recently in France and the Federal Republic of Germany. This resistance phenotype is due to the production of new plasmid-mediated, broad-substrate-range beta-lactamases designated TEM-3 to TEM-7. DNA-DNA hybridization analysis with a probe specific for TEM-1 indicated that the corresponding genes blaT-3 to blaT-7 were variants of the structural genes for TEM-type beta-lactamases. In the present studies, a 2.5-kilobase BamHI plasmid DNA fragment encoding TEM-3 was cloned in E. coli, and the entire nucleotide sequence of blaT-3 was determined. The deduced amino acid sequence of TEM-3 differed in two positions from that of the TEM-2 enzyme: lysine (TEM-3) was substituted for glutamic acid (TEM-2) at residue 104 and serine (TEM-3) for glycine (TEM-2) at residue 238 in the numbering system of Ambler. Spontaneous mutants of TEM penicillinases with increased activity against third-generation cephalosporins were obtained in vitro by selection on cefotaxime or ceftazidime. It therefore appears that mutations in TEM-type beta-lactamases contribute to resistance to new-generation cephalosporins.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3055179     DOI: 10.1093/clinids/10.4.879

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  52 in total

1.  Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase.

Authors:  C E Smith; B S Tillman; A W Howell; R N Longfield; J H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

2.  Discrimination of extended-spectrum beta-lactamases by a novel nitrocefin competition assay.

Authors:  G A Papanicolaou; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

3.  Development of "oligotyping" for characterization and molecular epidemiology of TEM beta-lactamases in members of the family Enterobacteriaceae.

Authors:  C Mabilat; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

4.  Epidemiology of extended spectrum beta-lactamases.

Authors:  A Philippon; S Ben Redjeb; G Fournier; A Ben Hassen
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553

Review 5.  Resistance to third generation cephalosporins: the current situation.

Authors:  J C Pechère
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553

Review 6.  Classification of beta-lactamases: groups 1, 2a, 2b, and 2b'.

Authors:  K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

Review 7.  Characterization of beta-lactamases.

Authors:  K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

8.  Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in beta-lactamase following therapy with amoxicillin-clavulanic acid.

Authors:  V A Steingrube; R J Wallace; B A Brown; Y Pang; B Zeluff; L C Steele; Y Zhang
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

9.  Multiplicity of TEM-derived beta-lactamases from Klebsiella pneumoniae strains isolated at the same hospital and relationships between the responsible plasmids.

Authors:  C M Chanal; D L Sirot; A Petit; R Labia; A Morand; J L Sirot; R A Cluzel
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

10.  Integrated detection of extended-spectrum-beta-lactam resistance by DNA microarray-based genotyping of TEM, SHV, and CTX-M genes.

Authors:  Dirk M Leinberger; Verena Grimm; Maya Rubtsova; Jan Weile; Klaus Schröppel; Thomas A Wichelhaus; Cornelius Knabbe; Rolf D Schmid; Till T Bachmann
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.